The difficulty in standardization is in part due to the heterogeneous Tg immunoreactivity: differential splicing of Tg mRNA, various post-translational modifications, and alterations of biosynthesis regulation in thyroid tumor cells lead to exposure or masking of epitopes with resulting differences in Tg immunologic structure [23]. This evidence concerns the gene TG and thyroid tumor.